Novartis, IBM Watson Health team up for breast cancer project

ZURICH (Reuters) - Novartis has agreed to work with IBM Watson Health to explore ways to use patient data and advanced analysis to glean insights on the likely outcomes of breast cancer treatments, the Swiss drugmaker said on Monday.